Patients experiencing hormonal skin changes frequently report feeling unheard, and Doral Fredericks, PharmD, MBA, argues that active reassessment rather than attribution to aging is the clinical default that's needed.
Doral Fredericks, PharmD, MBA
Advertisement
Doral Fredericks, PharmD, MBA, is the Global VP of Medical Affairs and Outcomes Research at Organon.
Articles by Doral Fredericks, PharmD, MBA
Organon's Doral Fredericks, PharmD, MBA, explains why pregnancy and menopause remain chronically understudied in dermatology research and what clinicians are missing as a result.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
Breakout Bulletin: July 13-July 17
4
New York Extends Nurse Practitioner Independent Practice Authority Through 2030
5